Daily as of 3 Nov 16:00 ET
- Price
- below both $69.89 vs 50 $89.42 / 200 $77.22
- Projection
- 💀Death cross projected in 15 bars
- Test
- No active test
- Last cross
- 🟨Golden cross 10 Jul 2026 · projected 29 bars out
MNPR | Monopar TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$69.89
+$3.61 (+5.45%)
Monopar Therapeutics (MNPR) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2021.
Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since Jul 2026, but the two have been closing on each other and a death cross is projected within 20 bars. On both the daily and the 4-hour, price sits below the 50 and the 200; on the weekly it is between the two.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- between the two $70.32 vs 50 $76.34 / 200 $33.03
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 24 Feb 2025 · projected 27 bars out
4-hour as of 3 Nov 16:00 ET
- Price
- below both $69.89 vs 50 $74.44 / 200 $95.52
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 9 Oct 2026 · projected 30 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 9 Oct 2026 | 💀Death | 4-hour | 30 bars out | Not tested |
| 10 Jul 2026 | 🟨Golden steep | daily | 29 bars out | Not tested |
| 1 Jun 2026 | 🟨Golden | 4-hour | 24 bars out | 4 bar cross test |
| 26 Mar 2026 | 💀Death flat | daily | 27 bars out | Not tested |
| 9 Jan 2026 | 💀Death | 4-hour | 28 bars out | 2 bar cross test |
About MNPR
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$13.1M
4-hour coverageYes, since Oct 2025
History on recordSince 2021
SectorHealthcare
Cap bandsmall